These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18819413)

  • 1. [Temperate Legionella bacteriophage: discovery and characteristics].
    Grigor'ev AA; Bondarev VP; Borisevich IV; Darmov IV; Mironin AV; Zolotarev AG; Pogorel'skiĭ IP; Ianov DS
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):86-8. PubMed ID: 18819413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legionella pneumophila CRISPR-Cas Suggests Recurrent Encounters with One or More Phages in the Family
    Deecker SR; Urbanus ML; Nicholson B; Ensminger AW
    Appl Environ Microbiol; 2021 Aug; 87(17):e0046721. PubMed ID: 34132590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of Legionella bacteriophages in environmental water samples.
    Lammertyn E; Vande Voorde J; Meyen E; Maes L; Mast J; Anné J
    Microb Ecol; 2008 Jul; 56(1):191-7. PubMed ID: 17957402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.
    Blander SJ; Horwitz MA
    J Clin Invest; 1991 Mar; 87(3):1054-9. PubMed ID: 1999485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease.
    Blander SJ; Szeto L; Shuman HA; Horwitz MA
    J Clin Invest; 1990 Sep; 86(3):817-24. PubMed ID: 2203824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The nonspecific protection of guinea pigs immunized with a live tularemia vaccine against lung infection by Legionella pneumophila].
    Koniukhov VF; Tartakovskiĭ IS; Petrosov VV; Suchkov IuG; Prozorovskiĭ SV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):50-1. PubMed ID: 1950286
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Lehr KH; Ren J
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease.
    Blander SJ; Horwitz MA
    J Clin Invest; 1993 Feb; 91(2):717-23. PubMed ID: 8432872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of Legionella pneumophila antigen in urine of guinea pigs and humans with Legionnaires' disease.
    Williams A; Lever MS
    J Infect; 1995 Jan; 30(1):13-6. PubMed ID: 7751659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Higa F; Edelstein MA
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma adenosine deaminase activity in the early phase of Legionella pneumophila infection in guinea pigs.
    Nikaido Y; Nagata N; Kido M; Yoshida S
    FEMS Immunol Med Microbiol; 1996 May; 14(1):39-43. PubMed ID: 8804974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Legionnaires' Disease Update].
    Miyamoto H
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2018 Mar; 28(1):1-8. PubMed ID: 29562743
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
    Blander SJ; Horwitz MA
    J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of ØVC8 lytic phage for Vibrio cholerae O1.
    Solís-Sánchez A; Hernández-Chiñas U; Navarro-Ocaña A; De la Mora J; Xicohtencatl-Cortes J; Eslava-Campos C
    Virol J; 2016 Mar; 13():47. PubMed ID: 27000701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of azithromycin activity against Legionella spp.
    Edelstein PH
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legionnaires' Disease Mortality in Guinea Pigs Involves the p45 Mobile Genomic Element.
    Christensen LM; Sule P; Cirillo SLG; Strain M; Plumlee Q; Adams LG; Cirillo JD
    J Infect Dis; 2019 Oct; 220(10):1700-1710. PubMed ID: 31268152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model.
    Moffat JF; Edelstein PH; Regula DP; Cirillo JD; Tompkins LS
    Mol Microbiol; 1994 Jun; 12(5):693-705. PubMed ID: 8052122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens.
    Breiman RF; Horwitz MA
    J Exp Med; 1987 Mar; 165(3):799-811. PubMed ID: 3819647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.